FOXO3 and mantle cell lymphoma: In many MCL tumour tissues, FOXO3A is constitutively inactivated and it was reported that its reactivation by nuclear export inhibitors had profound impact on cell viability.53 We can only speculate that FOXO3A induction by chelation treatment would be also beneficial for MCL therapy.